Cancer gene therapy

A complete introduction and guide to the latest developments in cancer gene therapy-from bench to bedside. The authors comprehensively review the anticancer genes and gene delivery methods currently available for cancer gene therapy, including the transfer of genetic material into the cancer cells,...

Full description

Saved in:
Bibliographic Details
Other Authors: Curiel, David (Editor), Douglas, Joanne T. (Editor)
Format: Book
Language:English
Published: Totowa, New Jersey Humana Press 2005
Series:Contemporary cancer research
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-334671
005 20224271076
008 230127t20052005NJU a# #001 deng D
020 # # |a 9781588292131  |q hardback 
020 # # |a 1588292134  |q hardback 
040 # # |a DNLM  |d UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QZ 266 
090 0 0 |a QZ266  |b C21433 2004 
245 0 0 |a Cancer gene therapy  |c edited by David T. Curiel, Joanne T. Douglas 
264 # 1 |a Totowa, New Jersey  |b Humana Press  |c 2005 
264 # 4 |c ©2005 
300 # # |a xii, 489 pages  |b illustrations  |c 26 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
490 1 # |a Contemporary cancer research 
504 # # |a Includes bibliographical references and index 
520 # # |a A complete introduction and guide to the latest developments in cancer gene therapy-from bench to bedside. The authors comprehensively review the anticancer genes and gene delivery methods currently available for cancer gene therapy, including the transfer of genetic material into the cancer cells, stimulation of the immune system to recognize and eliminate cancer cells, and the targeting of the nonmalignant stromal cells that support their growth. They also thoroughly examine the advantages and limitations of the different therapies and detail strategies to overcome obstacles to their clinical implementation. Topics of special interest include vector-targeting techniques, the lessons learned to date from clinical trials of cancer gene therapy, and the regulatory guidelines for future trials. Noninvasive techniques to monitor the extent of gene transfer and disease regression during the course of treatment are also discussed 
650 1 2 |a Genetic Therapy 
650 2 2 |a Neoplasms  |x therapy 
700 1 # |a Curiel, David  |e editor 
700 1 # |a Douglas, Joanne T.  |e editor 
830 # 0 |a Contemporary cancer research 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=334671 
964 # # |c BOK  |d 01 
998 # # |a 00250##a006.2.2||00250##b006.2.2||00255##a006.2.2||00260##a006.2.2||00260##b006.2.2||00260##c006.2.2||00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00500##a006.2.2||00502##a006.2.2||00520##a006.2.2||00520##b006.2.2||00538##a006.2.2||00546##a006.2.2||00730##a006.2.2||00730##d006.4||00730##f006.10||00730##n006.2.2||00730##p006.2.2||